NYSE •
Healthcare •
Biotechnology •
Quote as of 09/09/2026 10:16
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization2,265.66 mln
Float118 mln
Earnings Date11/17/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
21.73
Exceptional upside
Relative Strength
89
/ 100
Strongly outperforming
Debt / Equity
24.30
Extremely leveraged
ROE
-943
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Biohaven Ltd. is a pharmaceutical company based in New Haven, Connecticut, focused on researching and bringing new medicines to patients with immune system disorders, neurological conditions, and cancer. The company has a broad portfolio of drug candidates at various stages of clinical testing, targeting conditions such as Parkinson's disease, epilepsy, rheumatoid arthritis, obesity, and several types of cancer, among others. A number of additional treatments are in earlier stages of research, addressing diseases ranging from type 1 diabetes to hearing disorders.
